UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000014868 |
|---|---|
| Receipt number | R000017285 |
| Scientific Title | Analysis of telomerase in patients with rheumatoid arthritis and connective tissue disease |
| Date of disclosure of the study information | 2014/08/15 |
| Last modified on | 2014/08/15 10:23:03 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Analysis of telomerase in patients with rheumatoid arthritis and connective tissue disease
Acronym
Analysis of telomerase in patients with rheumatoid arthritis and connective tissue disease
Scientific Title
Analysis of telomerase in patients with rheumatoid arthritis and connective tissue disease
Scientific Title:Acronym
Analysis of telomerase in patients with rheumatoid arthritis and connective tissue disease
Region
| Japan |
Condition
Condition
Rheumatoid arthritis and connective tissue disease
Classification by specialty
| Clinical immunology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To analyze telomerase activity of leukocyte in paitint with rheumatoid arthritis and connective tissue disease
Basic objectives2
Others
Basic objectives -Others
To investigate correlation between telomerase activity and serological factor
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Difference of telomerase activity between the diseases
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 100 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Patient with rheumatoid arthritis and connective tissue disease
Key exclusion criteria
Patient with malignancy
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Daitaro Kurosaka |
Organization
The Jikei University School of Medicine
Division name
Division of rheumatology, Department of Internal Medicine
Zip code
Address
19-18, 3chome, Nishishimbashi, Minatoku, Tokyo
TEL
0334331111
d_kurosaka@jikei.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kazuhiro Otani |
Organization
The Jikei University School of Medicine
Division name
Division of rheumatology, Department of Internal Medicine
Zip code
Address
19-18, 3chome, Nishishimbashi, Minatoku, Tokyo
TEL
0334331111
Homepage URL
md11-otani@jikei.ac.jp
Sponsor or person
Institute
The Jikei University School of Medicine, Division of rheumatology, Department of Internal Medicine
Institute
Department
Personal name
Funding Source
Organization
The Jikei University School of Medicine, Division of rheumatology, Department of Internal Medicine
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 08 | Month | 15 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2014 | Year | 08 | Month | 14 | Day |
Date of IRB
Anticipated trial start date
| 2014 | Year | 08 | Month | 15 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
To analyze telomerase activity of leukocyte in patient with rheumatoid arthritis and connective tissue disease
Management information
Registered date
| 2014 | Year | 08 | Month | 15 | Day |
Last modified on
| 2014 | Year | 08 | Month | 15 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017285
